BCL2 and familial pancreatic carcinoma: In pancreatic cancer, BCL-2 is frequently overexpressed and its overexpression confers chemo- and radioresistance and enhances tumorigenic and metastatic capability (Bold et al, 1999a,1999b; Nio et al, 2001; Su et al, 2001).